相关实验视频

Updated: Mar 30, 2026

Calcified Artery Preparation and Processing with Preserved Morphology and RNA for Digital Spatial Profiling

Calcified Artery Preparation and Processing with Preserved Morphology and RNA for Digital Spatial Profiling

Published on: January 23, 2026

空间奥米克斯策略用于研究人类动脉动脉样硬化的疾病

Jiaxin Wan¹, Zhi Sun², Xueqiong Feng²

¹Department of Neurointervention, the First Affiliated Hospital of Zhengzhou, University, Henan Provincial Neurointerventional Engineering Research Center, Zhengzhou, Henan, China.

Clinical and translational medicine

|March 29, 2025

概括

空间奥米克通过绘制斑块异质性的地图来推进动脉样硬化病的研究. 这项技术揭示了对疾病进展和潜在破裂机制的分子洞察力,有助于诊断.

科学领域:

心血管研究研究心血管研究
分子病理学分子病理学
生物医学工程生物医学工程

背景情况:

动脉样硬化涉及复杂的,异质的斑块,挑战目前的分类方法.
斑块的不稳定性和破裂导致严重的临床事件,如血栓形成和血管封闭.
传统的奥米克技术在分析组织内的微小分子细节方面存在局限性.

研究的目的:

审查用于研究动脉样硬化的空间奥米克的进展.
突出空间绘制如何增强对斑块异质性和疾病机制的理解.
探索在动脉样硬化脑血管疾病中的空间奥米克的诊断潜力.

主要方法:

关于用于动脉样硬化的空间奥米克技术的最新文献的综述.
分析空间奥米克如何可视化和量化动脉样硬化斑块内的分子组件.
专注于额外冠状动脉动脉缩性脑血管疾病模型.

主要成果:

空间奥米克能够详细可视化动脉样板内的分子异质性.
这些技术在研究微小的分子细节方面克服了传统奥米克学的局限性.
空间奥米学有助于识别疾病进展和破裂的潜在生物标志物.

结论:

空间奥米克为动脉样硬化病原和斑块不稳定性提供了新的见解.
它提供了研究疾病进展和确定治疗点的增强方法.
空间奥米克的应用有望改善动脉样硬化的诊断和管理.

关键词:

动脉样硬化动脉样硬化生物标志物生物标志物空间分布的空间分布空间奥米克斯空间奥米克斯血管床是一种血管床.

更多相关视频

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium

Published on: June 23, 2010

相关概念视频

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...